Journal Article

Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting

Wang, Yong-Jun, Zhao, Zhi-Gang, Sun, Xuan, Song, Li-Gang, Wang, Yi-Long, Li, Xiao-Qing, Ma, Ning, Li, Xin-Gang, Miao, Zhong-Rong, Mo, Da-Peng, Wang, Bo, Sun, Shu-Sen, Liu, Lian, Gao, Feng, Zhao, Xing-Quan

2016

Overview

Short-term combined use of clopidogrel and aspirin improves cerebrovascular outcomes in patients with symptomatic extracranial or intracranial stenosis. Antiplatelet non-responsiveness is related to recurrent ischemic events, but the culprit genetic variants responsible for the non-responsiveness have not been well studied. We aimed to identify the genetic variants associated with poor clinical outcomes. Patients with symptomatic extracranial or intracranial stenosis scheduled for stenting and receiving dual antiplatelets (clopidogrel 75 mg and aspirin 100 mg daily) for at least 5 days before intervention were enrolled. Ischemic events including recurrent transient ischemic attack, stroke, myocardial infarction, and vascular-related mortality within 12 months follow-up were recorded. We examined the influence of genetic polymorphisms on treatment outcome in our patients. A total of 268 patients were enrolled into our study and ischemic events were observed in 39 patients. For rs662 of paraoxonase 1 (PON1), allele C was associated with an increased risk of ischemic events (OR = 1.64, 95%CI = 1.03-2.62, P = 0.029). The A-allele carriers of rs2046934 of P2Y12 had a significant association with adverse events (OR = 2.01, 95%CI = 1.10-3.67, P = 0.041). The variant T-allele of cyclooxygenase-1 (COX1) rs1330344 significantly increased the risk of recurrent clinical events (OR = 1.85, 95%CI = 1.12-3.03, P = 0.017). The other single nucleotide polymorphism (SNP) had no association with ischemic events. PON1, P2Y12 and COX1 polymorphisms were associated with poorer vascular outcomes. Testing for these polymorphisms may be valuable in the identification of patients at risk for recurrent ischemic events.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Aged / Alleles / Aryldialkylphosphatase - genetics / Aspirin / Biology and Life Sciences / Blood platelets / Brain Ischemia - genetics / Brain Ischemia - pathology / Brain Ischemia - prevention & control / Brain research / Cardiovascular disease / Carotid arteries / Case-Control Studies / Cerebral infarction / Cerebrovascular system / Clinical outcomes / Clopidogrel / Complications and side effects / Cyclooxygenase 1 - genetics / Cyclooxygenase-1 / Cytochrome / Dosage and administration / Drug therapy / Female / Gene Frequency / Genetic aspects / Genetic Association Studies / Genetic diversity / Genetic Predisposition to Disease / Genetic variance / Genetic variation / Hospitals / Humans / Ischemia / Linkage Disequilibrium / Male / Medicine and Health Sciences / Metabolism / Metabolites / Middle Aged / Myocardial infarction / Neurology / Paraoxonase / Paraoxonase 1 / Patient outcomes / Patients / Pharmacy / Physiological aspects / Polymorphism / Polymorphism, Single Nucleotide / Receptors, Purinergic P2Y12 - genetics / Recurrence / Risk / Single-nucleotide polymorphism / Stenosis / Stents / Stroke / Studies / Transient ischemic attack